Melanocortin receptor agonists

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C514S253050, C514S254090, C514S253120, C514S253130, C544S363000, C544S364000, C544S373000

Reexamination Certificate

active

07314879

ABSTRACT:
The present invention relates to melanocortin receptor agonist of the formula (I): which is useful in the treatment for obesity, diabetes, and male and/or female sexual dysfunction

REFERENCES:
patent: 6294534 (2001-09-01), Nargund et al.
patent: WO 94 13696 (1994-06-01), None
patent: WO 99 55679 (1999-11-01), None
patent: WO 99 64002 (1999-12-01), None
patent: WO 00 74679 (2000-12-01), None
patent: WO 01 70337 (2001-09-01), None
patent: WO 01 70708 (2001-09-01), None
patent: WO 02 15909 (2002-02-01), None
patent: WO 02 059095 (2002-08-01), None
patent: WO 02 059107 (2002-08-01), None
patent: WO 02 059108 (2002-08-01), None
patent: WO 02 059117 (2002-08-01), None
patent: WO 02 070511 (2002-09-01), None
patent: 03/031410 (2003-04-01), None
Vippagunta et al. Advanced Drug Delivery Reviews, vol. 48, pp. 3-26 (2001).
Sebhat et al. Annual Reports in Medicinal Chemistry, vol. 38 pp. 31-40 (2003).
Campfield et al. Science, vol. 280 pp. 1383-1387 (1998).
Privileged structure based ligands for melanocortin receptors—4,4-Disubstituted piperidine derivatives. Kuklish, Steven L., et al., Bioorganic & Medicinal Chemistry Letters 16 (2006) 3843-3836.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Melanocortin receptor agonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Melanocortin receptor agonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Melanocortin receptor agonists will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2765529

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.